供者特异性抗体与肾移植活检中排斥转录本表达增加相关
在INTERCOMEX研究的1679例肾移植指征活检中,835例被归类为无排斥(NR)的活检有DSA检测结果,其中271例(32%)DSA阳性。NR活检中DSA阳性与抗体介导排斥(ABMR)相关转录本的轻度表达增加相关,尤其是IFNG诱导和NK细胞转录本。基于转录本表达构建的DSAProb分类器与ABMR概率分类器相似,在无分子或组织学排斥的活检中,DSAProb或ABMR概率评分升高与3年肾衰竭风险增加相关。
要点
- NR活检中DSA阳性率32%,与ABMR相关转录本轻度增加相关。
- DSAProb分类器可基于转录本表达预测DSA状态。
- 无排斥活检中ABMR样转录本梯度与DSA增加相关。
核心结论
- 许多目前认为无分子或组织学排斥的活检存在ABMR相关转录本的轻度增加,且与DSA频率增加相关。
研究设计与样本
- INTERCOMEX研究(NCT01299168)中1679例肾移植指征活检的微阵列分析,聚焦于自动原型聚类归类为无排斥(NR)的活检,其中835例有DSA检测结果。
主要发现
- NR活检中DSA阳性率为32%(271/835)。
- NR活检中DSA阳性与ABMR相关转录本轻度增加相关,尤其是IFNG诱导和NK细胞转录本。
- 基于转录本表达的DSAProb分类器与ABMR概率分类器相似。
- NR活检中分子ABMR样转录本表达梯度与DSA增加相关(P<2×10-16)。
- 无分子或组织学排斥的活检中,DSAProb或ABMR概率评分升高与3年肾衰竭风险增加相关。
临床怎么用
- 对于活检 classified 为无排斥但DSA阳性的肾移植患者,应关注ABMR相关转录本表达,可能提示亚临床ABMR。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Donor -specific HLA antibody (DSA) is present in many kidney transplant patients whose biopsies are classified as no rejection (NR). We explored whether in some NR kidneys DSA has subtle effects not currently being recognized. METHODS: We used microarrays to examine the relationship between standard-of-care DSA and rejection-related transcript increases in 1679 kidney transplant indication biopsies in the INTERCOMEX study (ClinicalTrials.gov NCT01299168), focusing on biopsies classified as NR by automatically assigned archetypal clustering. DSA testing results were available for 835 NR biopsies and were positive in 271 (32%). RESULTS: DSA positivity in NR biopsies was associated with mildly increased expression of antibody-mediated rejection (ABMR)-related transcripts, particularly IFNG-inducible and NK cell transcripts. We developed a machine learning DSA probability (DSAProb) classifier based on transcript expression in biopsies from DSA-positive versus DSA-negative patients, assigning scores using 10-fold cross-validation. This DSAProb classifier was very similar to a previously described "ABMR probability" classifier trained on histologic ABMR in transcript associations and prediction of molecular or histologic ABMR. Plotting the biopsies using Uniform Manifold Approximation and Projection revealed a gradient of increasing molecular ABMR-like transcript expression in NR biopsies, associated with increased DSA (P<2 × 10-16). In biopsies with no molecular or histologic rejection, increased DSAProb or ABMR probability scores were associated with increased risk of kidney failure over 3 years. CONCLUSIONS: Many biopsies currently considered to have no molecular or histologic rejection have mild increases in expression of ABMR-related transcripts, associated with increasing frequency of DSA. Thus, mild molecular ABMR-related pathology is more common than previously realized.
引用
- Madill-Thomsen KS, Böhmig GA, Bromberg J, et al. Donor-Specific Antibody Is Associated with Increased Expression of Rejection Transcripts in Renal Transplant Biopsies Classified as No Rejection. J Am Soc Nephrol. 2021. PMID: 34253587. doi:10.1681/ASN.2021040433
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。